ACMT Position Statement: Remove the Waiver Requirement for Prescribing Buprenorphine for Opioid Use Disorder

被引：15
|
作者：
Marino, Ryan [1 ]
Perrone, Jeanmarie [2 ]
Nelson, Lewis S. [3 ]
Wiegand, Timothy J. [4 ]
Schwarz, Evan S. [5 ]
Wax, Paul M. [6 ]
Stolbach, Andrew I. [7 ]
机构：
[1] Case Western Reserve Univ, Sch Med, Cleveland, OH 44106 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Rutgers New Jersey Med Sch, Newark, NJ USA
[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[5] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA
[6] Univ Texas Southwestern, Dallas, TX USA
[7] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
来源：
JOURNAL OF MEDICAL TOXICOLOGY | 2019年 / 15卷 / 04期
关键词：
Buprenorphine; Waiver; X-waiver; Opioid use disorder; Opioid agonist therapy; METHADONE; DEATHS;
D O I：
10.1007/s13181-019-00728-9
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
[No abstract available]
引用
收藏
页码：307 / 309
页数：3
相关论文
共 50 条
  • [31] Use of Buprenorphine to Treat Opioid Use Disorder
    Bartholow, Lydia Anne M.
    Pope, Justine
    [J]. JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES, 2018, 56 (11) : 9 - 12
  • [32] ACMT Position Statement: Interim Guidance for the Use of Lipid Resuscitation Therapy
    American College of Medical Toxicology
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2011, 7 (01) : 81 - 82
  • [33] ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
    Andrew I. Stolbach
    Maryann Mazer-Amirshahi
    Ryan Marino
    Lewis S. Nelson
    Jeremy Sugarman
    [J]. Journal of Medical Toxicology, 2020, 16 : 342 - 345
  • [34] ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
    Stolbach, Andrew, I
    Mazer-Amirshahi, Maryann
    Marino, Ryan
    Nelson, Lewis S.
    Sugarman, Jeremy
    [J]. JOURNAL OF MEDICAL TOXICOLOGY, 2020, 16 (03) : 342 - 345
  • [35] The Impact on Future Prescribing Patterns of Opioid Use Disorder (OUD) Education and Waiver Provision During Residency
    Boggiano, Victoria
    Wilson, Courtenay Gilmore
    Fagan, E. Blake
    Kirk, Julienne
    Bossenbroek-Fedoriw, Kelly
    Tak, Casey R.
    [J]. JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE, 2020, 33 (06) : 998 - 1003
  • [36] Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now
    D'Onofrio, Gail
    Melnick, Edward R.
    Hawk, Kathryn F.
    [J]. ANNALS OF EMERGENCY MEDICINE, 2021, 78 (02) : 220 - 222
  • [37] Preparing Medical Students to Care for Patients with Opioid Use Disorder: Buprenorphine Waiver Training in Undergraduate Medical Education
    Riser, Elly
    Kennedy, Amanda G.
    Holterman, Leigh Ann
    Brooklyn, John
    Maruti, Sanchit
    Sobel, Halle G.
    [J]. ACADEMIC PSYCHIATRY, 2024, 48 (03) : 263 - 267
  • [38] ACMT Position Statement: Limiting Harms of Vaping and E-cigarette Use
    Maryann Mazer-Amirshahi
    Fiona M. Garlich
    Diane P. Calello
    Andrew I. Stolbach
    [J]. Journal of Medical Toxicology, 2021, 17 : 87 - 90
  • [39] Overcoming Barriers to Prescribing Buprenorphine for the Treatment of Opioid Use Disorder: Recommendations from Rural Physicians
    Andrilla, C. Holly A.
    Moore, Tessa E.
    Patterson, Davis G.
    [J]. JOURNAL OF RURAL HEALTH, 2019, 35 (01): : 113 - 121
  • [40] Challenges in Treating Opioid Use Disorder Beyond the Waiver
    Akhter, Murtaza
    Dunham, Eleanor Fernandez
    [J]. ANNALS OF EMERGENCY MEDICINE, 2022, 79 (02) : 218 - 219
12345